The Baseline Tumor Size is an independent prognostic Factor for the progression-free but not the Overall Survival after Ipilimumab in Patients with metastatic malignant Melanoma

被引：0
|
作者：
Angelova, D. [1 ]
Weide, B. [2 ]
Heppt, M. [3 ]
Berking, C. [3 ]
Tietze, J. [1 ]
机构：
[1] Klinikum Augsburg, Dermatol, Augsburg, Germany
[2] Univ Hautklin Tubingen, Dermatol, Tubingen, Germany
[3] Ludwig Maximilians Univ Munchen, Dermatol, Munich, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P125
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
    Joseph, Richard W.
    Elassaiss-Schaap, Jeroen
    Kefford, Richard
    Hwu, Wen-Jen
    Wolchok, Jedd D.
    Joshua, Anthony M.
    Ribas, Antoni
    Hodi, F. Stephen
    Hamid, Omid
    Robert, Caroline
    Daud, Adil
    Dronca, Roxana
    Hersey, Peter
    Weber, Jeffrey S.
    Patnaik, Amita
    de Alwis, Dinesh P.
    Perrone, Andrea
    Zhang, Jin
    Kang, S. Peter
    Ebbinghaus, Scot
    Anderson, Keaven M.
    Gangadhar, Tara C.
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 4960 - 4967
  • [2] High baseline blood volume is an independent favorable prognostic factor for overall and progression-free survival in patients with metastatic renal cell carcinoma
    Drljevic-Nielsen, A.
    Rasmussen, F.
    Mains, J. R.
    Thorup, K.
    Donskov, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [4] Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma
    Abbott, Andrea M.
    Doepker, Matthew P.
    Kim, Youngchul
    Perez, Matthew C.
    Gandle, Cassandra
    Thomas, Kerry L.
    Choi, Junsung
    Shridhar, Ravi
    Zager, Jonathan S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 747 - 753
  • [5] Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival
    Rochefort, Pauline
    Chabaud, Sylvie
    Pierga, Jean-Yves
    Tredan, Olivier
    Brain, Etienne
    Bidard, Francois-Clement
    Schiffler, Camille
    Polena, Helena
    Khalil-Mgharbel, Abir
    Vilgrain, Isabelle
    Bachelot, Thomas
    BRITISH JOURNAL OF CANCER, 2017, 116 (03) : 356 - 361
  • [6] Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival
    Pauline Rochefort
    Sylvie Chabaud
    Jean-Yves Pierga
    Olivier Tredan
    Etienne Brain
    François-Clément Bidard
    Camille Schiffler
    Helena Polena
    Abir Khalil-Mgharbel
    Isabelle Vilgrain
    Thomas Bachelot
    British Journal of Cancer, 2017, 116 : 356 - 361
  • [7] Serum thymidine kinase activity is an independent prognostic factor for progression-free and overall survival in women with metastatic breast cancer
    Larsson, Anna-Maria
    Jansson, Sara
    Bendahl, Par-Ola
    Baker, Sara
    Bergqvist, Mattias
    Aaltonen, Kristina
    Ryden, Lisa
    CANCER RESEARCH, 2018, 78 (04)
  • [8] Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome
    Yizhuo Zhang
    Qing Guo
    Haifeng Zhao
    Dandan Zhao
    Xiaoxiong Wu
    Weipeng Zhao
    Yafei Wang
    Bing Xia
    Wanming Da
    Medical Oncology, 2013, 30
  • [9] Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome
    Zhang, Yizhuo
    Guo, Qing
    Zhao, Haifeng
    Zhao, Dandan
    Wu, Xiaoxiong
    Zhao, Weipeng
    Wang, Yafei
    Xia, Bing
    Da, Wanming
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [10] Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma
    Guzman-Casta, Jordi
    Carrasco-CaraChards, Sonia
    Guzman-Huesca, Jorge
    Sanchez-Rios, Carla Paola
    Riera-Sala, Rodrigo
    Martinez-Herrera, Jose Fabian
    Pena-Mirabal, Erika Sagrario
    Bonilla-Molina, Diana
    Alatorre-Alexander, Jorge Arturo
    Martinez-Barrera, Luis Manuel
    Rodriguez-Cid, Jeronimo Rafael
    THORACIC CANCER, 2021, 12 (07) : 1014 - 1022
12345